The amount of alcohol intake, upper gastrointestinal bleeding, acute renal failure and hepatic encephalopathy as the risk factors implied in the increase in mortality in patients with alcoholic hepatitis;Cantidad de alcohol, hemorragia de tubo digestive alto, insuficiencia renal aguda y encefalopatía hepática como factores de riesgo implicados en el incremento de la mortalidad en pacientes con hepatitis por alcohol

Revista de Gastroenterologia de Mexico

Volumn 74, Issue 4, 2009, Pages 306-313

  Higuera De La Tijera, M F ^a   Perez Hernandez J L ^a   Servin Caamano A L ^a   Serralde Zuniga A E ^a   Cruz Palacios, A ^a  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

Acute renal failure; Alcoholic hepatitis; Hepatic encephalopathy; Mexico; Mortality; Risk factors

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; DRINKING BEHAVIOR; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HUMAN; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; UPPER GASTROINTESTINAL TRACT; YOUNG ADULT;

ACUTE KIDNEY INJURY; ADULT; AGED; ALCOHOL DRINKING; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HEPATITIS, ALCOHOLIC; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; UPPER GASTROINTESTINAL TRACT; YOUNG ADULT;

EID: 84864123816     PISSN: 03750906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Rodríguez A, Martínez R, García E, y cols. Tratamiento de la hepatitis tóxica grave por alcohol. Estudio comparativo entre dos medidas terapéuticas: sulfoadenosil-L-metionina (SAMe) vs SAMe más metilprednisolona. Med Int Mex 2004;20:18-23.
2. Mailliard ME, Sorrell ME. Hepatopatía alcohólica. En: Kasper DL, Braunwald E, Fauci AS, y cols., editores. Harrison Principios de Medicina Interna. 16ta. Edición. México, McGraw Hill Interamericana 2008:2043-6.
3. Cho Choi P, Hong Joo K, Hyuk Choi W, et al. Model for end-stage liver disease, model for end-stage liver disease-sodium and Child Turcotte Pugh scores over time for the prediction of complications of liver cirrhosis. Liver International 2009;1:221-6.
4. McCullough AJ, Barry O'Connor JF. Alcoholic liver disease: Proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998;93:2022-36. (Pubitemid 29076847)
5. Robert L, Carithers RL, McClain C. Alcoholic liver disease. En: Feldman M, Friedman LS, Brandt LJ, editores. Sleisenger and Fordtran's Gastrointestinal and Liver Disease; pathophysiology, diagnosis, management. 8th Edition. Philadelphia: Saunders Elsevier 2006:1771-88.
6. Schenker S. Alcoholic liver disease: Evaluation of natural history and prognostic factors. Hepatology 1984;4:36S-43S. (Pubitemid 14014195)
7. Punukollu R. The hepatorenal syndrome. Med Clin North Am 1990;74:933-44.
8. Mathurin P, et al. Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone. Hepatology 2003;38:1363-9. (Pubitemid 37466961)
9. Forrest EH, et al. The acute alcoholic hepatitis scoring system (Glasgow) improves the prediction of short and medium-term mortality. Hepatology 2003;38:264-5.
10. Imperiale TF, McCullogh AJ. Do corticosteroids reduce mortality from alcoholic hepatitis?. Ann Intern Med 1990;113:299-307.
11. Sass D, Shaikh O. Alcoholic hepatitis. Clin Liver Dis 2006;10:219-37. (Pubitemid 46110782)
12. Gralnek IM, Barkun AN, Bardou M. Management of acute bleeding from a peptic ulcer. N Engl J Med 2008;37:359-428.
13. Endre ZH, Westhuyzen J. Early detection of acute kidney injury: Emerging new biomarkers. Nephrology 2008;13:91-8. (Pubitemid 351229631)
14. González-Abraldes J, Mas A. Encefalopatía hepática, patogenia y formas clínicas. Medicine 2000;8:508-15.
15. Theodossi A, Eddleston ALWF, Williams R. Controlled trial of methylprednisolone in severe alcoholic hepatitis. Gut 1982;23:75-9. (Pubitemid 12170180)
16. Mathurin P, Duchatelle V, Ramond MJ, et al. Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 1996;110:1847-53. (Pubitemid 26169222)
17. Boetticher NC, Peine CJ, Kwo P, et al. A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology 2008;135:1953-60.
18. Kulkarni K, Tran T, et al. The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis. J Clin Gastroenterol 2004;38:453-9.
19. Altamirano-Gómez JT, Zapata-Irissón L, Augustin-Recio S, y cols. Utilidad clínica y predicción de supervivencia intrahospitalaria de 3 escalas pronósticas en hepatitis alcohólica. Rev Gastroenterol Méx 2009;74:18-25.